Hong Bryan Kun, Winer Jeffrey C, Martone James F, Wand Martin, Altman Bruce, Shields Bruce
Yale University School of Medicine, New Haven, CT, USA.
J Glaucoma. 2009 Mar;18(3):180-3. doi: 10.1097/IJG.0b013e31817eee0b.
To evaluate the efficacy of repeat 360-degree selective laser trabeculoplasty (SLT) in glaucoma patients with prior successful 360-degree SLT.
Retrospective chart review.
Forty-four eyes of 35 patients, > or =18 years of age, with open-angle glaucoma (primary open-angle, pseudoexfoliation, or pigmentary glaucoma), uncontrolled on maximum tolerable medical therapy, underwent an initial 360-degree SLT (SLT1), which was successful for > or =6 months, but eventually lost efficacy and was followed by a repeat 360-degree SLT (SLT2). Patients with prior argon laser trabeculoplasty or other glaucoma surgery, before or during the study period, were excluded. Intraocular pressure (IOP) measurements were recorded before each procedure and 1 to 4 weeks, 1 to 3 months, and 5 to 8 months posttreatment and 15 to 21 weeks after the initial SLT.
Reduction in IOP after SLT1 and SLT2 was significantly less with repeat treatment at 1 to 3 months, with average decreases of -5.0 and -2.9 mm Hg, respectively (P=0.01), but there were no statistically significant differences between treatments at the other equivalent time points. Using a definition of "success" as > or =20% peak IOP reduction, success rates for SLT1 and SLT2 were not significantly different. There was also no significant difference in eyes that received SLT2 6 to 12 months after SLT1 compared with those that received SLT2 12 months or more after SLT1.
Our findings suggest that repeat 360-degree SLT may be safe and effective after an initially successful 360-degree SLT has failed. These results may be achieved as early as 6 months after the first treatment.
评估重复360度选择性激光小梁成形术(SLT)对既往成功接受过360度SLT的青光眼患者的疗效。
回顾性病历审查。
35例年龄≥18岁的开角型青光眼(原发性开角型、假性剥脱性或色素性青光眼)患者,在最大耐受药物治疗下眼压仍未得到控制,接受了首次360度SLT(SLT1),治疗成功维持≥6个月,但最终失效,随后接受了重复360度SLT(SLT2)。排除在研究期间之前或期间接受过氩激光小梁成形术或其他青光眼手术的患者。在每次手术前以及治疗后1至4周、1至3个月、5至8个月和首次SLT后15至21周记录眼压测量值。
SLT1和SLT2后眼压降低在1至3个月重复治疗时显著减少,平均降低分别为-5.0和-2.9 mmHg(P = 0.01),但在其他等效时间点治疗之间无统计学显著差异。使用“成功”定义为眼压峰值降低≥20%,SLT1和SLT2的成功率无显著差异。与在SLT1后12个月或更长时间接受SLT2的患者相比,在SLT1后6至12个月接受SLT2的患者中也无显著差异。
我们的研究结果表明,在最初成功的360度SLT失败后,重复360度SLT可能是安全有效的。这些结果最早可在首次治疗后6个月实现。